The functional role of these ligands in immune response activation along with their positive correlation with ZC3H12A gene, indicates that CRC patients with lower ZC3H12A expression evade immune surveillance, therefore exhibiting worse prognosis and more aggressive tumor features as demonstrated in this study. Here, ZC3H12A is linked to neoplasm.